Hossein Sadeghi, MD
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Credentials & Experience
Board Certifications
- Pediatrics
- Sleep Medicine
- Pediatric Pulmonology
Clinical Expertise
- Asthma
- Bronchiolitis
- Bronchoscopy
- Cystic Fibrosis
- Global Health
- Pediatric Bronchoscopy
- Pediatric Pulm Hypertension
- Pediatric Pulmonary Diseases
- Pediatric Pulmonary Medicine
- Pediatric Sleep Disorders
- Pediatric Sleep Medicine
- Restless Legs Syndrome
- Restless Leg Syndrome
- Sleep Disorders In Children
Specialties
Education & Training
- University of Queensland (Australia)
- Internship: Medical College of Virginia Hospitals
- Residency: Medical College of Virginia Hospitals
- Fellowship: New York Medical College
About Hossein Sadeghi
Dr. Sadeghi has served on numerous advisory and review panels including serving on the editorial board of the virtual international pediatric pulmonology network subcommittee of American Thoracic Society. He is board certified in sleep medicine, pediatric pulmonology and pediatrics. He has implemented public health measures for pediatric asthma in Stamford, Connecticut that helped reduce the length of stay for inpatient admissions, improve care in the emergency department with better communication to the primary care physicians, improve health delivery to the underserved population by setting up a monthly pro-bono clinic and raise the level of education in the community and primary care providers.
In addition, Dr. Sadeghi set up cystic fibrosis care at Tully Health Center in Stamford, Connecticut. He was instrumental in establishing the field of pediatric pulmonology in Iran. Globally, he has set up lectures, conferences and educational sessions on cystic fibrosis to educate healthcare providers. As part of this plan, he brought cystic fibrosis patients to the United States from Iran for treatment and management by gathering a coalition of local hospital, academic institution, Cystic Fibrosis Foundation, interfaith groups, representatives and senators, pharmaceutical companies and law firms.
Academic Titles
- Associate Professor of Pediatrics
Administrative Positions
- Director, Sue and John L. Weinberg Cystic Fibrosis Center
Hospital Affiliations
- NewYork-Presbyterian Morgan Stanley Children's Hospital
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Signature Administrators
- Student Health
Affinity
- Essential Plan
- Medicaid Managed Care
Amida Care
- Special Needs Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Connecticare
- Medicare Managed Care
- Passage (Exchange)
- POS
- POS (Exchange)
Elderplan
- Medicare Managed Care
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- EPO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Medicare
- Traditional Medicare (NY)
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
TRICARE
- TRICARE
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Contact & Locations
New York, New York 10032
Suite 11
Stamford, Connecticut 06902
Research
Clinical Trials
NCT02677701 TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Grants
APHASE 3, OPEN-LABEL, ROLLOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH TAZACAFFOR IN COMBINATION WITH TIVACAFTOR IN SUBJECTS WITH CYSTIC FIBROSYS AGED 6 YEARS AND OLDER, MOMOZYGOUS OR HETEROZYGOUS FOR THE F508DEL-CFTR MUTAT (P&S Industry Clinical Trial)
Sep 11 2018 - Sep 11 2023
APHASE 3, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF VX-661 IN COMBINATION WITH IVACAFTOR IN SUBJECTS 6 THROUGH 11 YEARS OF AGE WITH CYSTIC FIBROSIS, HOMOZYGOUS (P&S Industry Clinical Trial)
Feb 22 2018 - Feb 22 2023
ANOBSERVATIONAL, NON INTERNVENTIONAL STUDY IN THE UNITED STATES TO CHARACTERIZE RESPIRATORY SYNCTIAL VIRUS HOSPITALIZATIONS AMONG INFANCE BORN AT 29 TO 35 WEEKS GESTATIONAL AGE NOT RECEIVING IMMUNOPROPHYLAXIS (P&S Industry Clinical Trial)
Feb 2 2015 - Feb 2 2020
AWARD FOR A PHYSICAL THERAPIST (Private)
Nov 1 2016 - Oct 31 2019
FIRST AND SECOND YEAR CLINICAL FELLOWSHIP-RAI (Private)
Jul 1 2017 - Jun 30 2019
PROSPECTIVE STUDY OF PERIPHERALLY INSERTED VENOUS CATHETERS IN CF PATIENTS (Private)
Jul 1 2018 - Jun 30 2019
RARE CFTR MUTATION CELL COLLECTION PROTOCOL (RARE) (Private)
Mar 1 2016 - Feb 28 2019
OPTIMIZING- TREATMENT FOR EARLY PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS: THE OPTIMIZE MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED TRAIL (Federal Gov)
Sep 15 2013 - Jun 30 2018
CF LEARNING NETWORK: PROPOSAL FOR PILOTING A LEARNING HEALTH SYSTEM (Private)
Jun 1 2017 - Dec 31 2017
NY 21/21 PEDIATRIC CENTER RESEARCH NURSE COORDINATOR (Private)
Jan 1 2016 - Dec 31 2017
NY 21/21 PEDIATRIC CENTER RESEARCH NURSE COORDINATOR (Private)
Jan 1 2016 - Dec 31 2017
TEACHTRIAL: TESTING THE EFFECT OF ADDING CHRONIC AZITHROMYCIN TI INHALED TOBRAMYCIN. A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL OF AZITHROMYCIN 500MG THRICE WEEKLY IN COMBINATION WITH INH (Private)
Jan 1 2016 - Dec 31 2016
CF CENTER RENEWAL 2015-2016 (Private)
Jul 1 2015 - Jun 30 2016
CFF-FIRST AND SECOND YEAR CLINICAL FELLOWSHIP TRAINING GRANT (Private)
Jul 1 2014 - Jun 30 2016
ONE CF CENTER: LEARNING AND LEADERSHIP COLLABORATIVE 2 (Private)
Dec 1 2014 - Mar 31 2016
COLUMBIA UNIVERSITY THERAPEUTICS DEVELOPMENT CENTER (Private)
Jan 1 2009 - Dec 31 2013